New York State Common Retirement Fund
ONCT

New York State Common Retirement Fund’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

New York State Common Retirement Fund’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19
Closed – – 3516
2022
Q2 		$0 Sell
19
-765
-98% -$17.1K ﹤0.01% 3568
2022
Q1 		$22K Hold
784
– – ﹤0.01% 3282
2021
Q4 		$36K Sell
784
-3
-0.4% -$202 ﹤0.01% 3268
2021
Q3 		$66K Sell
787
-1,108
-58% -$91.7K ﹤0.01% 3214
2021
Q2 		$180K Buy
+1,895
New +$225K ﹤0.01% 3084
2019
Q2 		– Sell
-39
Closed -$7K – 3313
2019
Q1 		$7K Hold
39
– – ﹤0.01% 3157
2018
Q4 		$4K Hold
39
– – ﹤0.01% 3181
2018
Q3 		$9K Hold
39
– – ﹤0.01% 3140
2018
Q2 		$84K Buy
+39
New +$98.9K ﹤0.01% 3111

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

New York State Common Retirement Fund's ONCT Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2022, closing a stake of 19 shares.

New York State Common Retirement Fund first reported a position in ONCT in Q2 2018 and held it in 9 quarters. The position peaked at $180K in Q2 2021. 61 funds tracked by Wall St. Rank hold ONCT as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 19 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • New York State Common Retirement Fund's Oncternal Therapeutics, Inc. Common Stock position peaked at $180K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.